JP2025118743A5 - - Google Patents
Info
- Publication number
- JP2025118743A5 JP2025118743A5 JP2025075768A JP2025075768A JP2025118743A5 JP 2025118743 A5 JP2025118743 A5 JP 2025118743A5 JP 2025075768 A JP2025075768 A JP 2025075768A JP 2025075768 A JP2025075768 A JP 2025075768A JP 2025118743 A5 JP2025118743 A5 JP 2025118743A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- cancer
- optionally substituted
- acid
- reporting moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662438575P | 2016-12-23 | 2016-12-23 | |
| US62/438,575 | 2016-12-23 | ||
| US201762519534P | 2017-06-14 | 2017-06-14 | |
| US62/519,534 | 2017-06-14 | ||
| JP2019534737A JP7784103B2 (ja) | 2016-12-23 | 2017-12-21 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
| PCT/US2017/068025 WO2018119313A1 (en) | 2016-12-23 | 2017-12-21 | Tumor and immune cell imaging based on pd-l1 expression |
| JP2022207606A JP7680759B2 (ja) | 2016-12-23 | 2022-12-23 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022207606A Division JP7680759B2 (ja) | 2016-12-23 | 2022-12-23 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025118743A JP2025118743A (ja) | 2025-08-13 |
| JP2025118743A5 true JP2025118743A5 (https=) | 2026-01-21 |
Family
ID=62627749
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534737A Active JP7784103B2 (ja) | 2016-12-23 | 2017-12-21 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
| JP2022207606A Active JP7680759B2 (ja) | 2016-12-23 | 2022-12-23 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
| JP2025075768A Pending JP2025118743A (ja) | 2016-12-23 | 2025-04-30 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534737A Active JP7784103B2 (ja) | 2016-12-23 | 2017-12-21 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
| JP2022207606A Active JP7680759B2 (ja) | 2016-12-23 | 2022-12-23 | Ｐｄ－ｌ１発現に基づく腫瘍および免疫細胞イメージング |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11607466B2 (https=) |
| EP (1) | EP3558395A4 (https=) |
| JP (3) | JP7784103B2 (https=) |
| KR (2) | KR102662725B1 (https=) |
| CN (1) | CN110366432A (https=) |
| AU (1) | AU2017382282B9 (https=) |
| BR (1) | BR112019012986A2 (https=) |
| CA (1) | CA3048229A1 (https=) |
| IL (1) | IL267572B2 (https=) |
| MX (1) | MX2019007615A (https=) |
| WO (1) | WO2018119313A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| CN109512798B (zh) * | 2019-01-15 | 2022-05-13 | 南京从一医药科技有限公司 | 一种用于抗肿瘤免疫治疗的药物组合物纳米体系 |
| CN111662270A (zh) * | 2019-03-05 | 2020-09-15 | 中国医学科学院药物研究所 | 碘同位素标记苄苯醚衍生物、及其制法和药物组合物与用途 |
| CN110898234B (zh) * | 2019-12-25 | 2020-12-22 | 河南大学 | 一种二维铋纳米复合材料及其制备方法和应用 |
| TWI833056B (zh) | 2019-12-31 | 2024-02-21 | 財團法人工業技術研究院 | 核酸藥物複合體以及其用途 |
| CN112067586B (zh) * | 2020-06-24 | 2021-08-03 | 江南大学 | 一种基于荧光淬灭拉曼增强的前列腺特异性抗原双信号光谱分析方法 |
| CA3188677A1 (en) * | 2020-08-07 | 2022-02-10 | Sridhar Nimmagadda | Imaging and targeting programmed death ligand-1 (pd-li) expression |
| DE102020130954A1 (de) | 2020-11-23 | 2022-05-25 | Universität Duisburg-Essen | Markierungspartikel für Raman-Streuung und/oder Fluoreszenz-Strahlung |
| CN114853851B (zh) * | 2021-02-04 | 2023-08-15 | 南方医科大学南方医院 | 靶向pd-l1多肽探针及其在制备pet显像剂中的应用 |
| CN113341023B (zh) * | 2021-06-30 | 2022-12-23 | 大连医科大学附属第一医院 | 一种基于液质联用的血清二氨基庚二酸的检测试剂盒及检测方法与应用 |
| WO2023014999A1 (en) * | 2021-08-06 | 2023-02-09 | The Johns Hopkins University | Aluminum fluoride radiosynthesis of [18f]dk222 |
| CN115364247A (zh) * | 2021-09-15 | 2022-11-22 | 中国人民解放军海军军医大学第一附属医院 | 一种靶向显影剂、制备方法及其应用 |
| CN114010655B (zh) * | 2021-11-02 | 2023-02-03 | 安徽医科大学第一附属医院 | 一种识别和降解前列腺癌细胞表面的pd-l1的金纳米星及其制备方法和应用 |
| CN114569745A (zh) * | 2022-03-18 | 2022-06-03 | 哈尔滨医科大学 | 一种靶向pd-l1的多肽pet分子成像探针及其制备方法与应用 |
| AU2024344671A1 (en) * | 2023-09-20 | 2026-03-26 | Trimt Gmbh | Functionalized peptides for in-vivo addressing of pd-l1 expression |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ542371A (en) * | 2003-03-19 | 2008-10-31 | Universitatsspital Basel | Radiolabeled conjugates based on substance P and the uses thereof |
| AU2009333580B2 (en) | 2008-12-09 | 2016-07-07 | Genentech, Inc. | Anti-PD-L1 antibodies and their use to enhance T-cell function |
| WO2012074840A2 (en) * | 2010-11-22 | 2012-06-07 | The General Hospital Corporation | Compositions and methods for in vivo imaging |
| US20140316255A1 (en) * | 2011-09-02 | 2014-10-23 | Ellis Garai | Raman Imaging Devices and Methods of Molecular Imaging |
| US11268958B2 (en) * | 2012-09-14 | 2022-03-08 | The Johns Hopkins University | Bacteria-specific labeled substrtates as imaging biomarkers to diagnose, locate, and monitor infections |
| US9308236B2 (en) | 2013-03-15 | 2016-04-12 | Bristol-Myers Squibb Company | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions |
| TN2017000084A1 (en) * | 2014-09-11 | 2018-07-04 | Bristol Myers Squibb Co | Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions |
| ES2981335T3 (es) * | 2014-11-25 | 2024-10-08 | Bristol Myers Squibb Co | Novedosos polipéptidos de unión a PD-L1 para obtención de imágenes |
| US9861680B2 (en) | 2014-12-18 | 2018-01-09 | Bristol-Myers Squibb Company | Immunomodulators |
| US9944678B2 (en) | 2014-12-19 | 2018-04-17 | Bristol-Myers Squibb Company | Immunomodulators |
| US20160222060A1 (en) | 2015-02-04 | 2016-08-04 | Bristol-Myers Squibb Company | Immunomodulators |
| HUE054306T2 (hu) * | 2016-05-19 | 2021-08-30 | Bristol Myers Squibb Co | Immunmodulátorok PET-képalkotás számára |
| CN107869033B (zh) * | 2016-09-26 | 2020-10-02 | 青岛胶南海尔洗衣机有限公司 | 一种干衣机用正反转风扇及干衣机 |
-
2017
- 2017-12-21 BR BR112019012986A patent/BR112019012986A2/pt unknown
- 2017-12-21 CA CA3048229A patent/CA3048229A1/en active Pending
- 2017-12-21 MX MX2019007615A patent/MX2019007615A/es unknown
- 2017-12-21 IL IL267572A patent/IL267572B2/en unknown
- 2017-12-21 JP JP2019534737A patent/JP7784103B2/ja active Active
- 2017-12-21 KR KR1020197021481A patent/KR102662725B1/ko active Active
- 2017-12-21 US US16/471,678 patent/US11607466B2/en active Active
- 2017-12-21 KR KR1020247003223A patent/KR20240023665A/ko not_active Ceased
- 2017-12-21 AU AU2017382282A patent/AU2017382282B9/en active Active
- 2017-12-21 WO PCT/US2017/068025 patent/WO2018119313A1/en not_active Ceased
- 2017-12-21 EP EP17883237.4A patent/EP3558395A4/en active Pending
- 2017-12-21 CN CN201780087531.0A patent/CN110366432A/zh active Pending
-
2022
- 2022-12-23 JP JP2022207606A patent/JP7680759B2/ja active Active
-
2025
- 2025-04-30 JP JP2025075768A patent/JP2025118743A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025118743A5 (https=) | ||
| JP6977958B2 (ja) | Ｐｓｍａを標的としたイメージング及び放射線治療のための金属／放射性金属標識ｐｓｍａ阻害剤 | |
| ES2977715T3 (es) | Inhibidores marcados de antígeno prostático específico de membrana (psma), su uso como agentes formadores de imágenes y agentes farmacéuticos para el tratamiento de cáncer de próstata | |
| CA2489469C (en) | Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer | |
| IL318462A (en) | Fap-alpha specific tumor diagnostic imaging agent | |
| ES2736134T3 (es) | Derivado peptídico de tiourea, compuesto marcado con radioisótopos que contiene el mismo y composición farmacéutica que contiene el mismo como ingrediente activo para tratar o diagnosticar el cáncer de próstata | |
| JP2020514278A5 (https=) | ||
| BR112019023246B1 (pt) | Compostos compreendendo uma fração quelante, métodos para produção dos mesmos e usos dos mesmos | |
| Goodwin et al. | Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system | |
| JP5705434B2 (ja) | キレート剤 | |
| CN101626787A (zh) | 诊断的和治疗的环氧合酶-2结合配体 | |
| JP2025507966A (ja) | 核医学において用いられるセラノスティクスのための３つ以上の標的ベクターを有する標識前駆体および放射性トレーサー | |
| WO2025246177A1 (zh) | 一种靶向fap的二聚化合物及其探针和应用 | |
| Sharkey et al. | Bispecific antibody pretargeting of radionuclides for immuno–single-photon emission computed tomography and immuno–positron emission tomography molecular imaging: An update | |
| JPWO2022212958A5 (https=) | ||
| CA3243418A1 (en) | COMPOUNDS AND RADIOLIGANDS TO TARGET THE NEUROTENSIN RECEPTOR AND RELATED USES | |
| ES2985919T3 (es) | Agentes diagnósticos y terapéuticos dirigidos a CXCR4 con selectividad de especie reducida | |
| JP5404405B2 (ja) | 組織低酸素症の非侵襲的検出用の弱塩基性２−ニトロイミダゾール | |
| US10137212B2 (en) | Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications | |
| CN121079294A (zh) | 用于活性剂的多官能化的化合物核及其用途 | |
| JPWO2023057457A5 (https=) | ||
| EP0675737A1 (en) | Immunoreactive reagents employing dihydrofolate reductase | |
| TW200418880A (en) | Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient | |
| KR19990077198A (ko) | 감소된 순 양전하를 갖는 항체 | |
| CA2429632A1 (en) | Neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer |